Kymera Therapeutic
Trade Kymera Therapeutic 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About KYMR
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi on September 29, 2015 and is headquartered in Watertown, MA.
KYMR Key Statistics
Stock Snapshot
The current Kymera Therapeutic(KYMR) stock price is $82.34, with a market capitalization of 6.64B. The stock trades at a price-to-earnings (P/E) ratio of -22.90.
As of 2026-02-16, Kymera Therapeutic(KYMR) stock has fluctuated between $82.05 and $86.18. The current price stands at $82.34, placing the stock +0.4% above today's low and -4.5% off the high.
The Kymera Therapeutic(KYMR)'s current trading volume is 572.04K, compared to an average daily volume of 835.38K.
During the past year, Kymera Therapeutic(KYMR) stock moved between $19.45 at its lowest and $103.00 at its peak.
During the past year, Kymera Therapeutic(KYMR) stock moved between $19.45 at its lowest and $103.00 at its peak.
Analyst ratings
92%
of 24 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.